نتایج جستجو برای: fluconazole

تعداد نتایج: 4748  

Journal: :Journal of clinical pathology 1999
P C Huijgens A M Simoons-Smit A C van Loenen E Prooy H van Tinteren G J Ossenkoppele A R Jonkhoff

AIMS To compare the efficacy of and tolerance to oral fluconazole and intraconazole in preventing fungal infection in neutropenic patients with haematological malignancies. PATIENTS 213 consecutive, afebrile adult patients treated with or without autologous stem cell transplantation for haematological malignancies. METHODS A randomised, double blind, single centre study. Patients were rando...

2015
Maria Helena Figueiral Patrícia Fonseca Maria Manuel Lopes Eugénia Pinto Teresa Pereira-Leite Benedita Sampaio-Maia

Denture-related stomatitis (DRS) is the most common condition affecting removable-denture wearers, and Candida albicans the most frequent pathogenic agent. Systemic antifungal treatment is indicated but recurrences are frequent. The aim of this study was to characterize the oral load, fluconazole susceptibility profile and genotypic variability of oral C. albicans isolates from patients with DR...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006
Jose A Vazquez Daniel J Skiest Leopoldo Nieto Rebeca Northland Ian Sanne Jagadish Gogate Wayne Greaves Randi Isaacs

BACKGROUND Oropharyngeal candidiasis is the most common opportunistic infection among persons infected with human immunodeficiency virus (HIV). Use of some agents is hampered by lack of efficacy, emergence of resistance, adverse events, and need for intravenous administration. Posaconazole is an extended-spectrum triazole with potent in vitro activity against Candida species, including Candida ...

Journal: :Antimicrobial agents and chemotherapy 2007
Neeraj Chauhan Michael Kruppa Richard Calderone

Hypersensitivity to the triazoles fluconazole and voriconazole associated with two-component signal transduction proteins has not been reported in Candida albicans. Herein, we show that strains of C. albicans lacking the response regulator Ssk1p or the Chk1p histidine kinase signal transduction proteins are hypersensitive to fluconazole and voriconazole compared to wild-type (wt) as well as gen...

Journal: :Canadian family physician Medecin de famille canadien 2015
Yusuf Cem Kaplan Gideon Koren Shinya Ito Pina Bozzo

QUESTION I have a patient with persistent breast and nipple thrush. Other therapies have failed, so I have decided to treat her with a loading dose of 400 mg of oral fluconazole followed by 100 mg twice daily for at least 2 weeks. Is there any need for her to interrupt breastfeeding during this treatment? ANSWER Available data regarding fluconazole use during breastfeeding are reassuring. Flu...

Journal: :Antimicrobial agents and chemotherapy 2001
A L Baltch R P Smith M A Franke W J Ritz P B Michelsen L H Bopp

This study evaluates the effects of cytokines, used singly and in combination, on the microbicidal activity of human monocyte-derived macrophages (MDM) against intracellular Candida albicans in the presence and absence of fluconazole. In the absence of fluconazole, the addition of tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), gamma interferon (IFN-gamma), or IL-4 had no...

Journal: :The Annals of pharmacotherapy 2001
J S Burkiewicz K A Kostiuk R A Jacobs B J Guglielmo

OBJECTIVE To evaluate both the economic and clinical impact of an intravenous fluconazole restriction policy in a university teaching hospital. METHODS Intravenous fluconazole was restricted to patients unable to take oral medications due to significant nausea or to patients whose oral intake was restricted. A retrospective chart review and computerized record review was conducted in patients...

Journal: :Antimicrobial agents and chemotherapy 1995
T Parkinson D J Falconer C A Hitchcock

We report on the mechanism of fluconazole resistance in Candida glabrata from a case of infection in which pre- and posttreatment isolates were available for comparison. The resistant, posttreatment isolate was cross-resistant to ketoconazole and itraconazole, in common with other azole-resistant yeasts. Resistance was due to reduced levels of accumulation of [3H]fluconazole rather than to chan...

Journal: :Antimicrobial agents and chemotherapy 2015
Nina T Grossman Cau D Pham Angela A Cleveland Shawn R Lockhart

Candida parapsilosis is the second or third most common cause of candidemia in many countries. The Infectious Diseases Society of America recommends fluconazole as the primary therapy for C. parapsilosis candidemia. Although the rate of fluconazole resistance among C. parapsilosis isolates is low in most U.S. institutions, the resistance rate can be as high as 7.5%. This study was designed to a...

2012
Chen-Hsiang Lee Tzu-Yao Chang Jien-Wei Liu Fang-Ju Chen Chun-Chih Chien Ya-Fen Tang Cheng-Hsien Lu

BACKGROUND This study aimed to investigate the correlation of minimum inhibiting concentrations (MICs), obtained by broth micro-dilution, and clinical response in patients with cryptococcal meningitis. METHODS Using retrospective analyses covering the period 2001-2010, factors affecting clinical therapeutic cure in patients with cryptococcal meningitis 10 weeks after the start of anti-fungal ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید